The present invention relates to a method of identifying a base at a target position in a sample nucleic acid sequence wherein a primer, which hybridizes to the sample nucleic acid immediately adjacent to the target position, is provided and the sample nucleic acid and primer are subjected to a polymerase reaction in the presence of a nucleotide whereby the nucleotide will only become incorporated if it is complementary to the base in the target position, and said incorporation is detected, characterized in that, a single-stranded nucleic acid binding protein is included in the polymerase reaction step.
Thomas D. Willis - San Francisco CA, US Paul Hardenbol - Los Altos CA, US Maneesh Jain - Menlo Park CA, US Viktor Stolc - Cupertino CA, US Mostafa Ronaghi - Palo Alto CA, US Ronald W. Davis - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12P019/34 C12Q001/68 C07H021/02 C07H021/04
US Classification:
435 911, 435 6, 435 912, 536 243, 536 231
Abstract:
The invention is directed to novel methods of multiplexing nucleic acid reactions, including amplification, detection and genotyping. The invention relies on the use of precircle probes that are circularized in the presence of the corresponding target nucleic acids, cleaved, and then amplified.
Pål Nyren - Stockholm, SE Mostafa Ronaghi - Palo Alto CA, US Annika Tallsjö - Uppsala, SE
Assignee:
Biotage AB - Uppsala
International Classification:
C12Q 1/68
US Classification:
436 6, 536 221
Abstract:
The present invention provides a method of identifying a base at a target position in a sample nucleic acid sequence, said method comprising: subjecting a primer hybridised to said sample nucleic acid immediately adjacent to the target position, to a polymerase primer extension reaction in the presence of a nucleotide, whereby the nucleotide will only become incorporated if it is complementary to the base in the target position, and determining whether or not said nucleotide is incorporated by detecting whether Ppi is released, the identity of the target base being determined from the identity of any nucleotide incorporated, wherein, where said nucleotide comprises an adenine base, an α-thio triphosphate analogue of said nucleotide is used, and the Rp isomer of said analogue and/or the degradation products of said analogue are eliminated from the polymerase reaction step.
Methods And Compositions For Clonal Amplification Of Nucleic Acid
Mostafa Ronaghi - Palo Alto CA, US Foad Mashayekhi - San Francisco CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12P 19/34 C12Q 1/68 C07H 21/02 C07H 21/04
US Classification:
435 912, 435 6, 536 231, 536 243
Abstract:
Described herein are methods and compositions relating to amplifying nucleic acid. In certain embodiments, the invention provides methods for labeling and amplifying a nucleic acid molecule.
Pal Nyren - Stockholm, SE Mostafa Ronaghi - Palo Alto CA, US Annika Tallsjo - Uppsala, SE
Assignee:
Qiagen GmbH - Hilden
International Classification:
C12Q 1/68
US Classification:
435 6, 435 911, 536 221, 536 2433
Abstract:
The present invention provides a method of identifying a base at a target position in a sample nucleic acid sequence, said method comprising: subjecting a primer hybridised to said sample nucleic acid immediately adjacent to the target position, to a polymerase primer extension reaction in the presence of a nucleotide, whereby the nucleotide will only become incorporated if it is complementary to the base in the target position, and determining whether or not said nucleotide is incorporated by detecting whether PPi is released, the identity of the target base being determined from the identity of any nucleotide incorporated, wherein, where said nucleotide comprises an adenine base, an α-thio triphosphate analogue of said nucleotide is used, ant the Rp isomer of said analogue and/or the degradation products of said analogue are eliminated from the polymerase reaction step.
Thomas D Willis - San Francisco CA, US Paul Hardenbol - Los Altos CA, US Maneesh Jain - Menlo Park CA, US Viktor Stolc - Cupertino CA, US Mostafa Ronaghi - Palo Alto CA, US Ronald W Davis - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
C12P 19/34 C12Q 1/68 C07H 21/02 C07H 21/04
US Classification:
435 911, 435 6, 435 912, 536 243, 536 231
Abstract:
The invention is directed to novel methods of multiplexing nucleic acid reactions, including amplification, detection and genotyping. The invention relies on the use of precircle probes that are circularized in the presence of the corresponding target nucleic acids, cleaved, and then amplified.
Mostafa Ronaghi - Los Altos Hills CA, US Ali Agah - Campbell CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
H03M 1/66
US Classification:
341143, 341118, 341155, 341120
Abstract:
An error-corrected representation of an input signal, such as a bioluminescence signal, is generated. An analog representation of the input signal is oversampled and quantized to provide a first-stage digital output and a residual error. The residual error is provided as a second-stage digital output using successive approximation. The first-stage and second-stage digital outputs are used to generate an error-corrected representation of the bioluminescence signal.
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 1/68 C12P 19/34
US Classification:
435 6, 435 912
Abstract:
The present method involves sequencing by synthesis in which a template strand having an attached primer is immobilized in a small volume reaction mixture. In one embodiment, the reaction mixture is in contact with a sensitive heat sensor, which detects the heat of reaction from incorporation of a complementary base (dNTP) in the presence of appropriate reagents (DNA polymerase, and polymerase reaction buffer). Alternatively, or in addition, a change in pH resulting from the incorporation of nucleotides in the DNA polymerase reaction is measured. A device is provided having delivery channels for appropriate reagents, including dNTPs, which may be delivered sequentially or in a mixture. Preferably, the dNTPs are added in a predetermined sequence, and the dNTP is incorporated or not depending on the template sequence.
Name / Title
Company / Classification
Phones & Addresses
Mostafa Ronaghi Director
AURORA ALGAE RGV, LLC
3325 Investment Blvd, Hayward, CA 94545
Mostafa Ronaghi
Ronaghi Group, LLC Real Estate Investment
1671 The Alameda, San Jose, CA 95126 6 Results Way, Cupertino, CA 95014
Mostafa Ronaghi
Rona Maskan LLC
1982 Camino A Los Cerros, Menlo Park, CA 94025 250 King St, San Francisco, CA 94107
Mostafa Ronaghi Executive Vice-President
Venrock Associates III, L.P Investor
3340 Hillview Ave, Palo Alto, CA 94304 650 561-9580
Mostafa Ronaghi President
Ronaghi Charitable Organization
165 Hawthorne Ave, Palo Alto, CA 94301
Mostafa Ronaghi President
Genotesta, Inc
250 King St, San Francisco, CA 94107 1982 Camino A Los Cerros, Menlo Park, CA 94025
Mostafa Ronaghi
Rona Syndicates, LLC Investment
370 Convention Way, Redwood City, CA 94063
Googleplus
Mostafa Ronaghi
Youtube
Next Generation Biotech with Mostafa Ronaghi
Dr. Ronaghi started as a molecular biologist and became a serial entre...
Duration:
57m 21s
Illumina Accelerator | Driving Value for Geno...
Meet some of our startups and coaches, including co-founders Mostafa R...
Duration:
3m 25s
1/30/13 - Mostafa Ronaghi, "Bridging the gap ...
Mostafa Ronaghi, Ph.D., joined Illumina in August 2008 and is responsi...
Duration:
1h
2013 Summit Webcast STEM CELLS AND GENOMICS ...
... AND GENOMICS MODERATOR - Jeanne F. Loring, PhD, The Scripps Resear...
essfully executed on multiple major initiatives, including launching the HiSeq 4000 and the recent introduction of MiniSeq. As President and CEO he will assume additional leadership responsibility for the G&A and Research organizations, headed by Marc Stapley and Mostafa Ronaghi respectively.
Date: Mar 07, 2016
Category: Business
Source: Google
Illumina Launches GRAIL, Focused on Blood-Based Cancer Screening
., Ph.D., physician In Chief at Memorial Sloan Kettering and president of the American Association of Cancer Research; Dr. Brian Druker, M.D., director of the Oregon Health & Science University (OHSU) Knight Cancer Institute; Mostafa Ronaghi, Ph.D., Illumina SVP and CTO; Donald A. Berry, Ph.D.,